Skip to main content
Signal8

Marshall Richard Peter

SEC insider (Form 3/4/5 filer). CIK 0002016188. Director at Serina Therapeutics, Inc. (SER). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in HUNTSVILLE, AL.

Companies Marshall Richard Peter has filed insider reports for

  • Serina Therapeutics, Inc. (SER): Director
Marshall Richard Peter profile photo

Marshall Richard Peter

CIK: 0002016188

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Serina Therapeutics, Inc. logo
SER

Serina Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Serina Therapeutics, Inc. logo
    SER

    Serina Therapeutics, Inc.

    Jun 17, 2026
    Award

    Stock Option (right to buy)

    Direct
    15.3K shares-
  • Serina Therapeutics, Inc. logo
    SER

    Serina Therapeutics, Inc.

    May 19, 2026
    Purchase
    Direct
    12.2K shares at avg. $1.65$20K
  • Serina Therapeutics, Inc. logo
    SER

    Serina Therapeutics, Inc.

    Nov 7, 2025
    Award

    Stock Option (right to buy)

    Direct
    10K shares-

1-3 of 3